A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder
Joseph Biederman, Frank A. Lopez, Samuel W. Boellner, Mark C. Chandler
Research output: Contribution to journal › Article › peer-review
167Scopus
citations
Fingerprint
Dive into the research topics of 'A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder'. Together they form a unique fingerprint.